Skip to main content
NIH funding notice PAR-21-314

Blueprint MedTech: Incubator Hubs (U54 Clinical Trial Not Allowed)

Closed on October 20, 2021.

Posted
August 20, 2021
Close date
October 20, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,000,000 in first-year total cost, median $1,000,000.

Most frequent study sections

  1. Special Emphasis Panel[ZEB1 OSR-D (M1)]2

Most frequent institutions

  1. JOHNS HOPKINS UNIVERSITY1
  2. MASSACHUSETTS GENERAL HOSPITAL1
Competing awards under PAR-21-314 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022Center for Innovative NeuroTech Advancement - CINTA1U54EB033650-01BONATO, PAOLOSCHACHTER, STEVEN C.MASSACHUSETTS GENERAL HOSPITAL, MA$1,000,000ZEB1
2022NeuroTech Harbor: Our nation's first equitech ecosystem for neuromedical technologies1U54EB033664-01ETIENNE-CUMMINGS, RALPHMANAYE, KEBRETEN FNWULIA, EVARISTUS ASARMA, SRIDEVI V.THAKOR, NITISH VYOMESHYAZDI, YOUSEPHJOHNS HOPKINS UNIVERSITY, MD$1,000,000ZEB1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-21-314: Blueprint MedTech: Incubator Hubs (U54 Clinical Trial Not Allowed) | ScienceDex | ConductScience